GILEAD SCIENCES, INC. Quarterly Marketable Securities, Current in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Gilead Sciences, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2010 to Q2 2024.
  • Gilead Sciences, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $0 -$963M -100% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $0 -$936M -100% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.18B +$206M +21.2% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $1.16B +$198M +20.6% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $963M +$39M +4.22% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $936M -$93M -9.04% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $973M -$209M -17.7% Dec 31, 2022 10-K 2024-02-23
Q3 2022 $961M -$415M -30.2% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $924M -$708M -43.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.03B -$572M -35.7% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $1.18B -$229M -16.2% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $1.38B -$9.71B -87.6% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $1.63B -$10.5B -86.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.6B -$9.13B -85.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.41B -$11.3B -88.9% Dec 31, 2020 10-K 2022-02-23
Q3 2020 $11.1B -$2.29B -17.1% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $12.2B -$3.78B -23.7% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $10.7B -$243M -2.21% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $12.7B +$572M +4.71% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $13.4B -$515M -3.71% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $15.9B +$3.26B +25.7% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $11B -$5.38B -32.9% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $12.1B -$5.77B -32.2% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $13.9B -$2.98B -17.7% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $12.7B +$299M +2.41% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 $16.4B +$12.5B +327% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $17.9B +$14.3B +389% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $16.9B +$14.4B +587% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $12.4B +$10.1B +446% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $3.83B +$1.83B +91.1% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $3.67B +$1.91B +109% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $2.46B +$708M +40.5% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $2.27B +$1.07B +89.9% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $2B +$1.35B +204% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $1.76B +$1.66B +1639% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $1.75B +$1.64B +1531% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $1.19B +$1.13B +1642% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $659M +$594M +916% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $101M +$82M +432% Dec 31, 2014 10-K 2016-02-24
Q3 2014 $107M Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $68.5M Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $64.9M -$13.9M -17.7% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $19M -$39.6M -67.6% Dec 31, 2013 10-K 2015-02-25
Q1 2013 $78.8M +$78.8M Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $58.6M +$42.1M +255% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $145M -$1.2B -89.3% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $82M -$1.28B -94% Jun 30, 2012 10-Q 2012-08-01
Q1 2012 $0 -$1.18B -100% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $16.5M -$1.17B -98.6% Dec 31, 2011 10-K 2013-02-27
Q3 2011 $1.35B +$63.2M +4.92% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $1.36B +$846M +163% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $1.18B +$460M +64.3% Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $1.19B Dec 31, 2010 10-K 2012-02-23
Q3 2010 $1.28B Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $518M Jun 30, 2010 10-Q 2010-08-09
Q1 2010 $715M Mar 31, 2010 10-Q 2010-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.